Zentek Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters
Zentek (NASDAQ:ZTEK) has withdrawn its submission to Health Canada's Pest Management Regulatory Agency (PMRA) for ZenGUARD™ Enhanced Air Filters. Based on PMRA feedback and analysis of the Canadian regulatory environment, the company will pursue alternative, more cost-effective and timely pathways to bring the product to market in Canada. The company had been evaluating these alternative options while awaiting PMRA assessment. ZenGUARD™ filters are designed to control infectious aerosols without significantly increasing energy consumption and emissions in buildings.
Zentek (NASDAQ:ZTEK) ha ritirato la sua domanda presso il Pest Management Regulatory Agency (PMRA) di Health Canada per i ZenGUARD™ Enhanced Air Filters. Sulla base dei feedback del PMRA e dell'analisi dell'ambiente normativo canadese, l'azienda seguirà percorsi alternativi, più economici e tempestivi, per immettere il prodotto sul mercato canadese. L'azienda stava valutando queste opzioni alternative mentre attendeva la valutazione del PMRA. I filtri ZenGUARD™ sono progettati per controllare gli aerosol infettivi senza aumentare significativamente il consumo energetico e le emissioni negli edifici.
Zentek (NASDAQ:ZTEK) ha retirado su solicitud ante el Pest Management Regulatory Agency (PMRA) de Health Canada para los ZenGUARD™ Enhanced Air Filters. Basándose en los comentarios del PMRA y el análisis del entorno regulatorio canadiense, la compañía buscará vías alternativas, más rentables y oportunas, para llevar el producto al mercado en Canadá. La empresa había estado evaluando estas opciones alternativas mientras esperaba la evaluación del PMRA. Los filtros ZenGUARD™ están diseñados para controlar aerosoles infecciosos sin aumentar significativamente el consumo de energía y las emisiones en los edificios.
ZenTek (NASDAQ:ZTEK)은 캐나다 보건부의 Pest Management Regulatory Agency (PMRA)에 ZenGUARD™ Enhanced Air Filters에 대한 제출을 철회했습니다. PMRA의 피드백과 캐나다의 규제 환경 분석을 바탕으로, 이 회사는 캐나다에서 제품을 시장에 출시하기 위한 대안적이고 더 비용 효율적이며 시기적절한 경로를 추구할 것입니다. 이 회사는 PMRA의 평가를 기다리는 동안 이러한 대안 옵션을 평가하고 있었습니다. ZenGUARD™ 필터는 건물의 에너지 소비와 배출을 크게 증가시키지 않으면서 전염성 에어로졸을 제어하도록 설계되었습니다.
Zentek (NASDAQ:ZTEK) a retiré sa soumission auprès de la Pest Management Regulatory Agency (PMRA) de Santé Canada pour les ZenGUARD™ Enhanced Air Filters. Sur la base des retours du PMRA et de l'analyse de l'environnement réglementaire canadien, l'entreprise poursuivra des voies alternatives, plus rentables et opportunes, pour commercialiser le produit au Canada. L'entreprise avait évalué ces options alternatives tout en attendant l'évaluation du PMRA. Les filtres ZenGUARD™ sont conçus pour contrôler les aérosols infectieux sans augmenter de manière significative la consommation d'énergie et les émissions dans les bâtiments.
Zentek (NASDAQ:ZTEK) hat seinen Antrag bei der Pest Management Regulatory Agency (PMRA) von Health Canada für die ZenGUARD™ Enhanced Air Filters zurückgezogen. Basierend auf dem Feedback der PMRA und der Analyse des kanadischen Regulierungsumfelds wird das Unternehmen alternative, kostengünstigere und zeitnahere Wege verfolgen, um das Produkt auf den kanadischen Markt zu bringen. Das Unternehmen hatte diese alternativen Optionen evaluiert, während es auf die Bewertung durch die PMRA wartete. Die ZenGUARD™-Filter sind darauf ausgelegt, infektiöse Aerosole zu kontrollieren, ohne den Energieverbrauch und die Emissionen in Gebäuden signifikant zu erhöhen.
- Company identified more cost-effective regulatory pathways to market
- Alternative pathways expected to be more time-efficient
- Withdrawal of regulatory submission to Health Canada PMRA
- Delay in Canadian market entry due to regulatory strategy shift
Insights
The withdrawal of PMRA submission for ZenGUARD™ Enhanced Air Filters represents a strategic pivot but raises concerns about market entry timeline and regulatory clarity. While the company suggests alternative pathways exist, the lack of specific details about these options creates uncertainty. The building decarbonization angle is compelling, with the
The company's air filtration technology could potentially capture market share in the growing green building solutions sector. However, the regulatory setback might delay revenue generation and market penetration. The strategic shift suggests potential cost savings on regulatory compliance, but success will depend heavily on the viability and speed of alternative pathways to market.
GUELPH, ON / ACCESSWIRE / October 31, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it has withdrawn its submission to the Health Canada Pest Management Regulatory Agency ("PMRA") for its ZenGUARD™ Enhanced Air Filters. Based on feedback received from PMRA, and continued analysis of the Canadian regulatory environment, the Company believes there are other, more cost-effective, and timely pathways, to bring ZenGUARD™ Enhanced Air Filters to market in Canada. The Company has been evaluating and planning for these potential alternative options in parallel with the PMRA assessment process over the last several months and will now shift its focus to these other pathways.
"Our top priority as a Company is ensuring we do everything we can to create value for our stakeholders as quickly and effectively as possible, which is why we are shifting our focus to pursue other pathways to market in Canada for ZenGUARD™ Enhanced Air Filters," said Greg Fenton, CEO of Zentek.
"Importantly, we know that one of the biggest challenges facing society is climate change and building decarbonization. Buildings contribute nearly
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™, is shown to have 99-per-cent antimicrobial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is in Guelph, Ontario.
For further information on Zentek:
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Zentek Ltd.
View the original press release on accesswire.com
FAQ
Why did Zentek withdraw its ZenGUARD filters submission from Health Canada PMRA?
What are the benefits of Zentek's ZenGUARD Enhanced Air Filters?
What is Zentek's (ZTEK) new strategy for ZenGUARD filters in Canada?
